Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Cortical Gyrification in Methamphetamine Associated Psychosis: A Potential Neurodevelopmental Biomarker for Risk of Psychosis
For many years, methamphetamine associated psychosis (MAP) has been viewed as a symptomatic, genetic, and morphological blueprint for schizophrenia spectrum disorders (SSD) (Aoki et al., 2013; Grant et al., 2012; Uhlmann et al., 2016; Yang et al., 2021). MAP is currently diagnosed as a substance ind...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | Eng |
| Published: |
Department of Psychology
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Cortical Gyrification in Methamphetamine Associated Psychosis: A Potential Neurodevelopmental Biomarker for Risk of Psychosis
- Executive functioning in methamphetamine psychosis
- Schneiderian first-rank symptoms in schizophrenia and methamphetamine psychosis: a comparative study
- Neural correlates of deficits in affect regulation in methamphetamine abusers with and without a history of psychosis
- Neurocircuitry of attention in methamphetamine induced psychosis: a comparison against schizophrenia patients and healthy controls
- Psychosis in Azheimer's Disease
- Modelling the pathophysiology of schizophrenia and methamphetamine-induced psychosis: A structural magnetic resonance imaging and cytokine study